DRUG DISCOVERY NEWS | The open-access Shared Platform for Antibiotic Research and Knowledge (SPARK) created by the Pew Charitable Trusts just got a boost from Novartis, which has shared data from its antibiotic research programs. This comes on the heels of biopharmaceutical company Achaogen’s recent commitment to give SPARK data from its own discontinued antibiotic research program.